Riastap Injection, Solution
Product Images NDC 63833-892

2 FDA label images from Csl Behring Gmbh · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Riastap (NDC 63833-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
Label for Riastap (Fibrinogen Human) injection, solution, a plasma derivative for intravenous administration. The label includes dosage information, manufacturer CSL Behring GmbH, and distributor CSL Behring LLC. Storage and reconstitution instructions are provided, along with barcodes and lot/expiration details.*
FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Principal Display Panel (50 mL Vial Carton)
Packaging label for Riastap (Fibrinogen Concentrate (Human)) injection, solution, one single-dose vial containing 900 mg to 1300 mg of lyophilized fibrinogen for reconstitution. The label includes manufacturer CSL Behring GmbH, and distributor CSL Behring LLC. It specifies for intravenous administration only and details storage conditions and ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.